AVITA Medical (ASX:AVH) Q1 2026 revenue rose 10% sequentially to US$19.3m but cash fell to US$14.3m as a new CEO and BARDA deal reset the story.
15
11
21
15
Stocks in Spotlight
View all →-
Growth Stocks · Financials Powerhouse Ventures (ASX:PVL) Merchant Model Delivers 22x and 240% Deal Wins July 15, 2026 -
AI Stocks · International Stocks SK hynix (NSDQ:SKHY) Surges 27% as Investors Reprice Its 58% HBM Leadership July 15, 2026 -
Financials · Growth Stocks Powerhouse Ventures (ASX:PVL) Builds a Merchant Revenue Engine as CIO Fund Scales July 3, 2026
